This is a $2,362.29 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3mL. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military healthcare....
The Defense Logistics Agency (DLA) awarded a $3,287.16 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which...
This is a $3,483.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is to supply the DLA with Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a prescription pharmaceutical product. The order has a completion date of June 11, 2024.
AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,408.64 firm fixed-price contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product. The order has an ultimate completion date of August 14, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with numerous Indefinite Delivery Contracts (IDCs) in...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,652.65 firm-fixed price contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award has an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the corporate office division of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,129.08 contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceuticals, with a completion date of February 13, 2024.
Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,544.10 firm fixed-price delivery order contract is for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $10,245.88 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a prescription medication, to support DLA operations. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a $3,483.24 firm fixed price delivery order awarded by the Medical Supply Chain component of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, with a period of performance through July 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a $4,118.64 delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has a firm-fixed-price pricing type and a period of performance through May 6, 2024.
Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the...